{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:25:58Z","timestamp":1791350758005,"version":"4.3.1"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T00:00:00Z","timestamp":1345766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T00:00:00Z","timestamp":1345766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1038\/nri3277","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T06:01:19Z","timestamp":1345788079000},"page":"636-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":179,"title":["The impact of differential antiviral immunity in children and adults"],"prefix":"10.1038","volume":"12","author":[{"given":"Andrew J.","family":"Prendergast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J. R.","family":"Goulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,24]]},"reference":[{"key":"BFnri3277_CR1","unstructured":"World Health Organization, UNAIDS & UNICEF. Global HIV\/AIDS response: Progress report 2011 (WHO, 2011)."},{"key":"BFnri3277_CR2","doi-asserted-by":"crossref","unstructured":"The Working Group on MTCT of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results of 13 perinatal studies. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8, 506\u2013510 (1995).","DOI":"10.1097\/00042560-199504120-00011"},{"key":"BFnri3277_CR3","doi-asserted-by":"crossref","unstructured":"Collaborative Group on AIDS Incubation and HIV Survival, including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 355, 1131\u20131137 (2000).","DOI":"10.1016\/S0140-6736(00)02061-4"},{"key":"BFnri3277_CR4","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","volume":"364","author":"ML Newell","year":"2004","unstructured":"Newell, M. L. . et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364, 1236\u20131243 (2004).","journal-title":"Lancet"},{"key":"BFnri3277_CR5","doi-asserted-by":"publisher","first-page":"e28510","DOI":"10.1371\/journal.pone.0028510","volume":"7","author":"R Becquet","year":"2012","unstructured":"Becquet, R. . et al. Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis. PLoS ONE 7, e28510 (2012).","journal-title":"PLoS ONE"},{"key":"BFnri3277_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/01.inf.0000264527.69954.4c","volume":"26","author":"E Marinda","year":"2007","unstructured":"Marinda, E. et al.Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr. Infect. Dis. J. 26, 519\u2013526 (2007). This study describes the natural history of perinatal HIV infection in a large cohort of infants prior to the availability of antiretroviral therapy; it demonstrates the importance of the timing of mother-to-child transmission in terms of disease outcome.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFnri3277_CR7","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1086\/315122","volume":"180","author":"RJ Biggar","year":"1999","unstructured":"Biggar, R. J. et al. Virus levels in untreated African infants infected with human immunodeficiency virus type 1. J. Infect. Dis. 180, 1838\u20131843 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/QAI.0b013e31819c16d8","volume":"51","author":"EM Obimbo","year":"2009","unstructured":"Obimbo, E. M. et al. Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality. J. Acquired Immune Defic. Syndr. 51, 209\u2013215 (2009).","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"BFnri3277_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1097\/00006454-199612000-00006","volume":"15","author":"K McIntosh","year":"1996","unstructured":"McIntosh, K. et al. Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus. Pediatr. Infect. Dis. J. 15, 1087\u20131091 (1996).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFnri3277_CR10","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1097\/00004836-200411003-00008","volume":"38","author":"B Custer","year":"2004","unstructured":"Custer, B. et al. Global epidemiology of hepatitis B virus. J. Clin. Gastroenterol. 38, S158\u2013S168 (2004).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnri3277_CR11","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/clinids\/20.4.992","volume":"20","author":"KC Hyams","year":"1995","unstructured":"Hyams, K. C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin. Infect. Dis. 20, 992\u20131000 (1995).","journal-title":"Clin. Infect. Dis."},{"key":"BFnri3277_CR12","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","volume":"2","author":"RP Beasley","year":"1983","unstructured":"Beasley, R. P. et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2, 1099\u20131102 (1983).","journal-title":"Lancet"},{"key":"BFnri3277_CR13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1067\/mob.2001.117968","volume":"185","author":"DZ Xu","year":"2001","unstructured":"Xu, D. Z. et al. Role of placental tissues in the intrauterine transmission of hepatitis B virus. Am. J. Obstet. Gynecol. 185, 981\u2013987 (2001).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnri3277_CR14","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.3748\/wjg.v17.i38.4321","volume":"17","author":"L Han","year":"2011","unstructured":"Han, L. et al. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J. Gastroenterol. 17, 4321\u20134333 (2011).","journal-title":"World J. Gastroenterol."},{"key":"BFnri3277_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","volume":"151","author":"BJ McMahon","year":"1985","unstructured":"McMahon, B. J. et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis. 151, 599\u2013603 (1985).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR16","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/oxfordjournals.aje.a116577","volume":"136","author":"CC Hsieh","year":"1992","unstructured":"Hsieh, C. C. et al. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study. Am. J. Epidemiol. 136, 1115\u20131121 (1992).","journal-title":"Am. J. Epidemiol."},{"key":"BFnri3277_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/rmv.535","volume":"17","author":"A Kenneson","year":"2007","unstructured":"Kenneson, A. & Cannon, M. J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 17, 253\u2013276 (2007).","journal-title":"Rev. Med. Virol."},{"key":"BFnri3277_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.544","volume":"17","author":"SC Dollard","year":"2007","unstructured":"Dollard, S. C., Grosse, S. D. & Ross, D. S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 17, 355\u2013363 (2007).","journal-title":"Rev. Med. Virol."},{"key":"BFnri3277_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jcv.2005.09.015","volume":"35","author":"RF Pass","year":"2006","unstructured":"Pass, R. F., Fowler, K. B., Boppana, S. B., Britt, W. J. & Stagno, S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol. 35, 216\u2013220 (2006).","journal-title":"J. Clin. Virol."},{"key":"BFnri3277_CR20","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1111\/j.1651-2227.2011.02538.x","volume":"101","author":"A Bevot","year":"2012","unstructured":"Bevot, A. et al. Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk. Acta Paediatr. 101, e167\u2013e172 (2012).","journal-title":"Acta Paediatr."},{"key":"BFnri3277_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-0031-1300971","volume":"29","author":"H Wakabayashi","year":"2012","unstructured":"Wakabayashi, H. et al. Low HCMV DNA copies can establish infection and result in significant symptoms in extremely preterm infants: a prospective study. Am. J. Perinatol. 29, 377\u2013382 (2012).","journal-title":"Am. J. Perinatol."},{"key":"BFnri3277_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jcv.2012.02.017","volume":"54","author":"J Nijman","year":"2012","unstructured":"Nijman, J. et al. Urine viral load and correlation with disease severity in infants with congenital or postnatal cytomegalovirus infection. J. Clin. Virol. 54, 121\u2013124 (2012).","journal-title":"J. Clin. Virol."},{"key":"BFnri3277_CR23","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/infdis\/148.6.953","volume":"148","author":"RF Pass","year":"1983","unstructured":"Pass, R. F., Stagno, S., Britt, W. J. & Alford, C. A. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J. Infect. Dis. 148, 953\u2013961 (1983).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR24","doi-asserted-by":"publisher","first-page":"7338","DOI":"10.1128\/JVI.00062-07","volume":"81","author":"E Belnoue","year":"2007","unstructured":"Belnoue, E., Fontannaz-Bozzotti, P., Grillet, S., Lambert, P. H. & Siegrist, C. A. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells. J. Virol. 81, 7338\u20137350 (2007). This study demonstrates differential CD8+ T cell activity between infants and adults in a murine LCMV model and shows that these differences contribute to persistent viral infection in infants.","journal-title":"J. Virol."},{"key":"BFnri3277_CR25","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ni719","volume":"2","author":"A Makrigiannakis","year":"2001","unstructured":"Makrigiannakis, A. et al. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nature Immunol. 2, 1018\u20131024 (2001).","journal-title":"Nature Immunol."},{"key":"BFnri3277_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1084\/jem.184.2.539","volume":"184","author":"I Roth","year":"1996","unstructured":"Roth, I. et al. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J. Exp. Med. 184, 539\u2013548 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnri3277_CR27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1126\/science.287.5452.498","volume":"287","author":"C Xu","year":"2000","unstructured":"Xu, C. et al. A critical role for murine complement regulator Crry in fetomaternal tolerance. Science 287, 498\u2013501 (2000).","journal-title":"Science"},{"key":"BFnri3277_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ni1037","volume":"5","author":"VR Aluvihare","year":"2004","unstructured":"Aluvihare, V. R., Kallikourdis, M. & Betz, A. G. Regulatory T cells mediate maternal tolerance to the fetus. Nature Immunol. 5, 266\u2013271 (2004).","journal-title":"Nature Immunol."},{"key":"BFnri3277_CR29","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1084\/jem.181.4.1445","volume":"181","author":"BF Haynes","year":"1995","unstructured":"Haynes, B. F. & Heinly, C. S. Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J. Exp. Med. 181, 1445\u20131458 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnri3277_CR30","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1126\/science.1196509","volume":"330","author":"JE Mold","year":"2010","unstructured":"Mold, J. E. et al. Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 330, 1695\u20131699 (2010).","journal-title":"Science"},{"key":"BFnri3277_CR31","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1126\/science.1164511","volume":"322","author":"JE Mold","year":"2008","unstructured":"Mold, J. E. et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322, 1562\u20131565 (2008). This study demonstrates that tolerance to maternal antigens is induced  in utero  through the induction of fetal CD4+CD25hiFOXP3+ regulatory T cells.","journal-title":"Science"},{"key":"BFnri3277_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.exphem.2004.03.012","volume":"32","author":"Y Takahata","year":"2004","unstructured":"Takahata, Y. et al. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp. Hematol. 32, 622\u2013629 (2004).","journal-title":"Exp. Hematol."},{"key":"BFnri3277_CR33","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.4049\/jimmunol.0901481","volume":"183","author":"TR Kollmann","year":"2009","unstructured":"Kollmann, T. R. et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 183, 7150\u20137160 (2009). This study demonstrates that, compared with those of adults, neonatal innate immune cells preferentially induce T H 17- and T H 2-type immune responses to provide protection against extracellular pathogens in early life.","journal-title":"J. Immunol."},{"key":"BFnri3277_CR34","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.4049\/jimmunol.160.10.4730","volume":"160","author":"SL Prescott","year":"1998","unstructured":"Prescott, S. L. et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J. Immunol. 160, 4730\u20134737 (1998).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nri2075","volume":"7","author":"O Levy","year":"2007","unstructured":"Levy, O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nature Rev. Immunol. 7, 379\u2013390 (2007).","journal-title":"Nature Rev. Immunol."},{"key":"BFnri3277_CR36","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/infdis\/jis186","volume":"205","author":"GM Scott","year":"2012","unstructured":"Scott, G. M. et al. Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J. Infect. Dis. 205, 1305\u20131310 (2012).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR37","first-page":"383","volume":"325","author":"L Pereira","year":"2008","unstructured":"Pereira, L. & Maidji, E. Cytomegalovirus infection in the human placenta: maternal immunity and developmentally regulated receptors on trophoblasts converge. Curr. Top. Microbiol. Immunol. 325, 383\u2013395 (2008).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnri3277_CR38","volume-title":"Infectious Diseases of the Fetus and Newborn","author":"DB Lewis","year":"2011","unstructured":"Lewis, D. B. & Wilson, C. B. in Infectious Diseases of the Fetus and Newborn (eds Remington, J.S. et al.) (Elsevier, 2011)."},{"key":"BFnri3277_CR39","doi-asserted-by":"publisher","first-page":"F230","DOI":"10.1136\/adc.2008.143438","volume":"94","author":"T Strunk","year":"2009","unstructured":"Strunk, T. et al. Reduced levels of antimicrobial proteins and peptides in human cord blood plasma. Arch. Dis. Child Fetal Neonatal Ed. 94, F230\u2013F231 (2009).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"BFnri3277_CR40","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1126\/science.1139522","volume":"317","author":"SY Zhang","year":"2007","unstructured":"Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522\u20131527 (2007).","journal-title":"Science"},{"key":"BFnri3277_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","volume":"25","author":"DB Stetson","year":"2006","unstructured":"Stetson, D. B. & Medzhitov, R. Type I interferons in host defense. Immunity 25, 373\u2013381 (2006).","journal-title":"Immunity"},{"key":"BFnri3277_CR42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.clim.2009.07.003","volume":"133","author":"ME Belderbos","year":"2009","unstructured":"Belderbos, M. E. et al. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin. Immunol. 133, 228\u2013237 (2009).","journal-title":"Clin. Immunol."},{"key":"BFnri3277_CR43","doi-asserted-by":"publisher","first-page":"e33419","DOI":"10.1371\/journal.pone.0033419","volume":"7","author":"ME Belderbos","year":"2012","unstructured":"Belderbos, M. E. et al. Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors. PLoS ONE 7, e33419 (2012).","journal-title":"PLoS ONE"},{"key":"BFnri3277_CR44","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.4049\/jimmunol.177.3.1956","volume":"177","author":"O Levy","year":"2006","unstructured":"Levy, O. et al. The adenosine system selectively inhibits TLR-mediated TNF-\u03b1 production in the human newborn. J. Immunol. 177, 1956\u20131966 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR45","doi-asserted-by":"publisher","first-page":"e10407","DOI":"10.1371\/journal.pone.0010407","volume":"5","author":"M Nguyen","year":"2010","unstructured":"Nguyen, M. et al. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS ONE 5, e10407 (2010).","journal-title":"PLoS ONE"},{"key":"BFnri3277_CR46","doi-asserted-by":"publisher","first-page":"e15041","DOI":"10.1371\/journal.pone.0015041","volume":"5","author":"NP Corbett","year":"2010","unstructured":"Corbett, N. P. et al. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS ONE 5, e15041 (2010).","journal-title":"PLoS ONE"},{"key":"BFnri3277_CR47","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1128\/IAI.70.12.6583-6588.2002","volume":"70","author":"JW Upham","year":"2002","unstructured":"Upham, J. W. et al. Development of interleukin-12-producing capacity throughout childhood. Infect. Immun. 70, 6583\u20136588 (2002).","journal-title":"Infect. Immun."},{"key":"BFnri3277_CR48","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1046\/j.1365-2567.1997.00343.x","volume":"92","author":"T Nakazawa","year":"1997","unstructured":"Nakazawa, T., Agematsu, K. & Yabuhara, A. Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells. Immunology 92, 180\u2013187 (1997).","journal-title":"Immunology"},{"key":"BFnri3277_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-3083.2007.01980.x","volume":"66","author":"Y Sundstrom","year":"2007","unstructured":"Sundstrom, Y. et al. The expression of human natural killer cell receptors in early life. Scand. J. Immunol. 66, 335\u2013344 (2007).","journal-title":"Scand. J. Immunol."},{"key":"BFnri3277_CR50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1203\/01.PDR.0000156501.55431.20","volume":"57","author":"JH Dalle","year":"2005","unstructured":"Dalle, J. H. et al. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr. Res. 57, 649\u2013655 (2005).","journal-title":"Pediatr. Res."},{"key":"BFnri3277_CR51","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1089\/aid.2004.20.1189","volume":"20","author":"HB Bernstein","year":"2004","unstructured":"Bernstein, H. B., Kinter, A. L., Jackson, R. & Fauci, A. S. Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. AIDS Res. Hum. Retroviruses 20, 1189\u20131195 (2004).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnri3277_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1203\/00006450-199305000-00010","volume":"33","author":"M Jenkins","year":"1993","unstructured":"Jenkins, M., Mills, J. & Kohl, S. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults. Pediatr. Res. 33, 469\u2013474 (1993).","journal-title":"Pediatr. Res."},{"key":"BFnri3277_CR53","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/jama.296.12.1498","volume":"296","author":"B Rodriguez","year":"2006","unstructured":"Rodriguez, B. et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296, 1498\u20131506 (2006).","journal-title":"JAMA"},{"key":"BFnri3277_CR54","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/jvi.68.9.6103-6110.1994","volume":"68","author":"P Borrow","year":"1994","unstructured":"Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M. & Oldstone, M. B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103\u20136110 (1994).","journal-title":"J. Virol."},{"key":"BFnri3277_CR55","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/jvi.68.7.4650-4655.1994","volume":"68","author":"RA Koup","year":"1994","unstructured":"Koup, R. A. et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650\u20134655 (1994).","journal-title":"J. Virol."},{"key":"BFnri3277_CR56","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.283.5403.857","volume":"283","author":"JE Schmitz","year":"1999","unstructured":"Schmitz, J. E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857\u2013860 (1999).","journal-title":"Science"},{"key":"BFnri3277_CR57","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.med.54.101601.152346","volume":"54","author":"M Carrington","year":"2003","unstructured":"Carrington, M. & O'Brien, S. J. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54, 535\u2013551 (2003).","journal-title":"Annu. Rev. Med."},{"key":"BFnri3277_CR58","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm0496-405","volume":"2","author":"RA Kaslow","year":"1996","unstructured":"Kaslow, R. A. et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med. 2, 405\u2013411 (1996).","journal-title":"Nature Med."},{"key":"BFnri3277_CR59","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature03113","volume":"432","author":"P Kiepiela","year":"2004","unstructured":"Kiepiela, P. et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432, 769\u2013775 (2004).","journal-title":"Nature"},{"key":"BFnri3277_CR60","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1089\/aid.1996.12.1691","volume":"12","author":"PJ Goulder","year":"1996","unstructured":"Goulder, P. J. et al. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res. Hum. Retroviruses 12, 1691\u20131698 (1996).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnri3277_CR61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm1520","volume":"13","author":"P Kiepiela","year":"2007","unstructured":"Kiepiela, P. et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nature Med. 13, 46\u201353 (2007).","journal-title":"Nature Med."},{"key":"BFnri3277_CR62","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/336484a0","volume":"336","author":"DF Nixon","year":"1988","unstructured":"Nixon, D. F. et al. HIV-1 Gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336, 484\u2013487 (1988).","journal-title":"Nature"},{"key":"BFnri3277_CR63","doi-asserted-by":"publisher","first-page":"8346","DOI":"10.1128\/JVI.00465-07","volume":"81","author":"H Crawford","year":"2007","unstructured":"Crawford, H. et al. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 81, 8346\u20138351 (2007).","journal-title":"J. Virol."},{"key":"BFnri3277_CR64","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1128\/JVI.80.7.3617-3623.2006","volume":"80","author":"J Martinez-Picado","year":"2006","unstructured":"Martinez-Picado, J. et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80, 3617\u20133623 (2006).","journal-title":"J. Virol."},{"key":"BFnri3277_CR65","doi-asserted-by":"publisher","first-page":"12382","DOI":"10.1128\/JVI.01543-07","volume":"81","author":"A Schneidewind","year":"2007","unstructured":"Schneidewind, A. et al. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 81, 12382\u201312393 (2007).","journal-title":"J. Virol."},{"key":"BFnri3277_CR66","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/QAI.0b013e318224d2e9","volume":"58","author":"OT Akinsiku","year":"2011","unstructured":"Akinsiku, O. T., Bansal, A., Sabbaj, S., Heath, S. L. & Goepfert, P. A. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression. J. Acquir. Immune Defic. Syndr. 58, 132\u2013140 (2011).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnri3277_CR67","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","volume":"107","author":"MR Betts","year":"2006","unstructured":"Betts, M. R. et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107, 4781\u20134789 (2006).","journal-title":"Blood"},{"key":"BFnri3277_CR68","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day, C. L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350\u2013354 (2006).","journal-title":"Nature"},{"key":"BFnri3277_CR69","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1128\/JVI.07034-11","volume":"86","author":"S Ferrando-Martinez","year":"2012","unstructured":"Ferrando-Martinez, S. et al. Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers. J. Virol. 86, 3667\u20133674 (2012).","journal-title":"J. Virol."},{"issue":"11","key":"BFnri3277_CR70","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ni845","volume":"3","author":"Stephen A. Migueles","year":"2002","unstructured":"Migueles, S. A. et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nature Immunol. 3, 1061\u20131068 (2002).","journal-title":"Nature Immunology"},{"key":"BFnri3277_CR71","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.immuni.2008.10.010","volume":"29","author":"SA Migueles","year":"2008","unstructured":"Migueles, S. A. et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29, 1009\u20131021 (2008).","journal-title":"Immunity"},{"key":"BFnri3277_CR72","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1128\/JVI.00315-12","volume":"86","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto, T. et al. Virus inhibition activity of effector memory CD8+ T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infection. J. Virol. 86, 5877\u20135884 (2012).","journal-title":"J. Virol."},{"key":"BFnri3277_CR73","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1128\/JVI.06150-11","volume":"86","author":"HN Kloverpris","year":"2012","unstructured":"Kloverpris, H. N. et al. HLA-B*57 micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control. J. Virol. 86, 919\u2013929 (2012).","journal-title":"J. Virol."},{"key":"BFnri3277_CR74","doi-asserted-by":"publisher","first-page":"8548","DOI":"10.1128\/JVI.00580-08","volume":"82","author":"PC Matthews","year":"2008","unstructured":"Matthews, P. C. et al. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J. Virol. 82, 8548\u20138559 (2008).","journal-title":"J. Virol."},{"key":"BFnri3277_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn, S. D. et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nature Immunol. 10, 29\u201337 (2009).","journal-title":"Nature Immunol."},{"key":"BFnri3277_CR76","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1073\/pnas.1009731107","volume":"107","author":"HT Jin","year":"2010","unstructured":"Jin, H. T. et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl Acad. Sci. USA 107, 14733\u201314738 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3277_CR77","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1084\/jem.20081398","volume":"205","author":"RB Jones","year":"2008","unstructured":"Jones, R. B. et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205, 2763\u20132779 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnri3277_CR78","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"BFnri3277_CR79","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nature07662","volume":"458","author":"V Velu","year":"2009","unstructured":"Velu, V. et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458, 206\u2013210 (2009).","journal-title":"Nature"},{"key":"BFnri3277_CR80","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/ni1515","volume":"8","author":"DE Kaufmann","year":"2007","unstructured":"Kaufmann, D. E. et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nature Immunol. 8, 1246\u20131254 (2007).","journal-title":"Nature Immunol."},{"key":"BFnri3277_CR81","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","volume":"12","author":"L Trautmann","year":"2006","unstructured":"Trautmann, L. et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nature Med. 12, 1198\u20131202 (2006).","journal-title":"Nature Med."},{"key":"BFnri3277_CR82","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1082305","volume":"300","author":"DJ Shedlock","year":"2003","unstructured":"Shedlock, D. J. & Shen, H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337\u2013339 (2003).","journal-title":"Science"},{"key":"BFnri3277_CR83","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1126\/science.1083317","volume":"300","author":"JC Sun","year":"2003","unstructured":"Sun, J. C. & Bevan, M. J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300, 339\u2013342 (2003).","journal-title":"Science"},{"key":"BFnri3277_CR84","doi-asserted-by":"publisher","first-page":"11983","DOI":"10.1128\/JVI.75.24.11983-11991.2001","volume":"75","author":"MR Betts","year":"2001","unstructured":"Betts, M. R. et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75, 11983\u201311991 (2001).","journal-title":"J. Virol."},{"key":"BFnri3277_CR85","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/8400","volume":"5","author":"CJ Pitcher","year":"1999","unstructured":"Pitcher, C. J. et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nature Med. 5, 518\u2013525 (1999).","journal-title":"Nature Med."},{"key":"BFnri3277_CR86","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1128\/JVI.05577-11","volume":"86","author":"S Ranasinghe","year":"2012","unstructured":"Ranasinghe, S. et al. HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome. J. Virol. 86, 277\u2013283 (2012).","journal-title":"J. Virol."},{"key":"BFnri3277_CR87","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307\u2013312 (2003).","journal-title":"Nature"},{"key":"BFnri3277_CR88","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ncomms1100","volume":"1","author":"KH Huang","year":"2010","unstructured":"Huang, K. H. et al. B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nature Commun. 1, 102 (2010).","journal-title":"Nature Commun."},{"key":"BFnri3277_CR89","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nri891","volume":"2","author":"DR Burton","year":"2002","unstructured":"Burton, D. R. Antibodies, viruses and vaccines. Nature Rev. Immunol. 2, 706\u2013713 (2002).","journal-title":"Nature Rev. Immunol."},{"key":"BFnri3277_CR90","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","volume":"449","author":"AJ Hessell","year":"2007","unstructured":"Hessell, A. J. et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449, 101\u2013104 (2007).","journal-title":"Nature"},{"key":"BFnri3277_CR91","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/515596","volume":"178","author":"EJ Abrams","year":"1998","unstructured":"Abrams, E. J. et al. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J. Infect. Dis. 178, 101\u2013108 (1998).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR92","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/00002030-200107060-00015","volume":"15","author":"RJ Biggar","year":"2001","unstructured":"Biggar, R. J. et al. Viral levels in newborn African infants undergoing primary HIV-1 infection. AIDS 15, 1311\u20131313 (2001).","journal-title":"AIDS"},{"key":"BFnri3277_CR93","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1086\/515637","volume":"178","author":"RE Dickover","year":"1998","unstructured":"Dickover, R. E. et al. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J. Infect. Dis. 178, 375\u2013387 (1998).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR94","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1097\/QAD.0b013e3281a3bec2","volume":"21","author":"W Mphatswe","year":"2007","unstructured":"Mphatswe, W. et al. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. AIDS 21, 1253\u20131261 (2007).","journal-title":"AIDS"},{"key":"BFnri3277_CR95","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1542\/peds.112.4.e289","volume":"112","author":"F Rouet","year":"2003","unstructured":"Rouet, F. et al. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics 112, e289 (2003).","journal-title":"Pediatrics"},{"key":"BFnri3277_CR96","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1056\/NEJM199705083361901","volume":"336","author":"WT Shearer","year":"1997","unstructured":"Shearer, W. T. et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N. Engl. J. Med. 336, 1337\u20131342 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnri3277_CR97","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4049\/jimmunol.154.1.433","volume":"154","author":"K Luzuriaga","year":"1995","unstructured":"Luzuriaga, K. et al. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J. Immunol. 154, 433\u2013443 (1995).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR98","doi-asserted-by":"publisher","first-page":"7134","DOI":"10.4049\/jimmunol.167.12.7134","volume":"167","author":"ZA Scott","year":"2001","unstructured":"Scott, Z. A. et al. Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8+ T cell responses in young HIV-1-infected infants. J. Immunol. 167, 7134\u20137140 (2001).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR99","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/QAD.0b013e328329c784","volume":"23","author":"S Shalekoff","year":"2009","unstructured":"Shalekoff, S. et al. Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers. AIDS 23, 789\u2013798 (2009).","journal-title":"AIDS"},{"key":"BFnri3277_CR100","doi-asserted-by":"publisher","first-page":"12775","DOI":"10.1128\/JVI.00624-07","volume":"81","author":"CF Thobakgale","year":"2007","unstructured":"Thobakgale, C. F. et al. Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants. J. Virol. 81, 12775\u201312784 (2007). This study shows that, even on the first day of life, HIV-specific CD8+ T cells can be detected in perinatally infected infants.","journal-title":"J. Virol."},{"key":"BFnri3277_CR101","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/35085576","volume":"412","author":"PJ Goulder","year":"2001","unstructured":"Goulder, P. J. et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412, 334\u2013338 (2001).","journal-title":"Nature"},{"key":"BFnri3277_CR102","doi-asserted-by":"crossref","unstructured":"Pillay, T. et al. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection. J. Virol. 79, 12100\u201312105 (2005).","DOI":"10.1128\/JVI.79.18.12100-12105.2005"},{"key":"BFnri3277_CR103","doi-asserted-by":"publisher","first-page":"10234","DOI":"10.1128\/JVI.00921-09","volume":"83","author":"CF Thobakgale","year":"2009","unstructured":"Thobakgale, C. F. et al. Impact of HLA in mother and child on paediatric HIV-1 disease progression. J. Virol. 83, 10234\u201310244 (2009).","journal-title":"J. Virol."},{"key":"BFnri3277_CR104","doi-asserted-by":"publisher","first-page":"8121","DOI":"10.1128\/JVI.79.13.8121-8130.2005","volume":"79","author":"BL Lohman","year":"2005","unstructured":"Lohman, B. L. et al. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific \u03b3 interferon responses during the first year of life in HIV-1-infected infants. J. Virol. 79, 8121\u20138130 (2005).","journal-title":"J. Virol."},{"key":"BFnri3277_CR105","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1089\/aid.2011.0081","volume":"27","author":"B Nqoko","year":"2011","unstructured":"Nqoko, B. et al. HIV-specific Gag responses in early infancy correlate with clinical outcome and inversely with viral load. AIDS Res. Hum. Retroviruses 27, 1311\u20131316 (2011).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnri3277_CR106","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.4049\/jimmunol.181.11.8103","volume":"181","author":"S Huang","year":"2008","unstructured":"Huang, S. et al. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment. J. Immunol. 181, 8103\u20138111 (2008).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR107","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/QAD.0b013e3283478575","volume":"25","author":"A Prendergast","year":"2011","unstructured":"Prendergast, A. et al. Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection. AIDS 25, 1329\u20131331 (2011).","journal-title":"AIDS"},{"key":"BFnri3277_CR108","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1089\/aid.2010.0227","volume":"27","author":"CF Thobakgale","year":"2011","unstructured":"Thobakgale, C. F. et al. Short communication: CD8+ T cell polyfunctionality profiles in progressive and nonprogressive pediatric HIV type 1 infection. AIDS Res. Hum. Retroviruses 27, 1005\u20131012 (2011).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnri3277_CR109","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/aid.2011.0113","volume":"28","author":"A Prendergast","year":"2012","unstructured":"Prendergast, A. et al. Factors influencing T cell activation and programmed death 1 expression in HIV-infected children. AIDS Res. Hum. Retroviruses 28, 465\u2013468 (2012).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnri3277_CR110","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/aid.2008.0138","volume":"25","author":"I Ssewanyana","year":"2009","unstructured":"Ssewanyana, I. et al. The distribution and immune profile of T cell subsets in HIV-infected children from Uganda. AIDS Res. Hum. Retroviruses 25, 65\u201371 (2009).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnri3277_CR111","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1084\/jem.20041455","volume":"201","author":"A Leslie","year":"2005","unstructured":"Leslie, A. et al. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J. Exp. Med. 201, 891\u2013902 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnri3277_CR112","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1128\/JVI.01743-09","volume":"84","author":"JG Prado","year":"2010","unstructured":"Prado, J. G. et al. Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate. J. Virol. 84, 492\u2013502 (2010).","journal-title":"J. Virol."},{"key":"BFnri3277_CR113","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.4049\/jimmunol.175.10.6976","volume":"175","author":"V Sanchez-Merino","year":"2005","unstructured":"Sanchez-Merino, V., Nie, S. & Luzuriaga, K. HIV-1-specific CD8+ T cell responses and viral evolution in women and infants. J. Immunol. 175, 6976\u20136986 (2005).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR114","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/QAD.0b013e32833a2b5b","volume":"24","author":"Y Tang","year":"2010","unstructured":"Tang, Y. et al. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57. AIDS 24, 1425\u20131435 (2010).","journal-title":"AIDS"},{"key":"BFnri3277_CR115","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1084\/jem.20071068","volume":"204","author":"DJ Hartigan-O'Connor","year":"2007","unstructured":"Hartigan-O'Connor, D. J., Abel, K. & McCune, J. M. Suppression of SIV-specific CD4+ T cells by infant but not adult macaque regulatory T cells: implications for SIV disease progression. J. Exp. Med. 204, 2679\u20132692 (2007). This study shows that T Reg  cells in infant, but not adult, macaques suppress SIV-specific CD4+ T cell responses, which can only be detected after the depletion of T Reg  cells.","journal-title":"J. Exp. Med."},{"key":"BFnri3277_CR116","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.4049\/jimmunol.171.12.6968","volume":"171","author":"ME Feeney","year":"2003","unstructured":"Feeney, M. E. et al. Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection. J. Immunol. 171, 6968\u20136975 (2003).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR117","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1086\/522013","volume":"196","author":"I Ssewanyana","year":"2007","unstructured":"Ssewanyana, I. et al. Profile of T cell immune responses in HIV-infected children from Uganda. J. Infect. Dis. 196, 1667\u20131670 (2007).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR118","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jaci.2004.11.054","volume":"115","author":"ME Paul","year":"2005","unstructured":"Paul, M. E. et al. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. J. Allergy Clin. Immunol. 115, 848\u2013855 (2005).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnri3277_CR119","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","volume":"17","author":"MD Hazenberg","year":"2003","unstructured":"Hazenberg, M. D. et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17, 1881\u20131888 (2003).","journal-title":"AIDS"},{"issue":"2","key":"BFnri3277_CR120","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nm0295-129","volume":"1","author":"T. H. Finkel","year":"1995","unstructured":"Finkel, T. H. et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1, 129\u2013134 (1995).","journal-title":"Nature Medicine"},{"key":"BFnri3277_CR121","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1086\/314660","volume":"179","author":"JV Giorgi","year":"1999","unstructured":"Giorgi, J. V. et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179, 859\u2013870 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR122","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1074-7613(03)00060-8","volume":"18","author":"G Silvestri","year":"2003","unstructured":"Silvestri, G. et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18, 441\u2013452 (2003).","journal-title":"Immunity"},{"key":"BFnri3277_CR123","doi-asserted-by":"publisher","first-page":"8002","DOI":"10.4049\/jimmunol.178.12.8002","volume":"178","author":"AP Barry","year":"2007","unstructured":"Barry, A. P. et al. Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species. J. Immunol. 178, 8002\u20138012 (2007).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","volume":"13","author":"FV Chisari","year":"1995","unstructured":"Chisari, F. V. & Ferrari, C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13, 29\u201360 (1995).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri3277_CR125","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/qjmed\/hcr270","volume":"105","author":"G Nebbia","year":"2012","unstructured":"Nebbia, G., Peppa, D. & Maini, M. K. Hepatitis B infection: current concepts and future challenges. QJM 105, 109\u2013113 (2012).","journal-title":"QJM"},{"key":"BFnri3277_CR126","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/nm1096-1104","volume":"2","author":"B Rehermann","year":"1996","unstructured":"Rehermann, B., Ferrari, C., Pasquinelli, C. & Chisari, F. V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med. 2, 1104\u20131108 (1996).","journal-title":"Nature Med."},{"key":"BFnri3277_CR127","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem, D. & Prince, A. M. Hepatitis B virus infection \u2014 natural history and clinical consequences. N. Engl. J. Med. 350, 1118\u20131129 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnri3277_CR128","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","volume":"49","author":"TJ Liang","year":"2009","unstructured":"Liang, T. J. Hepatitis B: the virus and disease. Hepatology 49, S13\u2013S21 (2009).","journal-title":"Hepatology"},{"key":"BFnri3277_CR129","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00277-011-1241-0","volume":"90","author":"YX Koo","year":"2011","unstructured":"Koo, Y. X. et al. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative\/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis. Ann. Hematol. 90, 1219\u20131223 (2011).","journal-title":"Ann. Hematol."},{"key":"BFnri3277_CR130","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1073\/pnas.0913498107","volume":"107","author":"PL Yang","year":"2010","unstructured":"Yang, P. L. et al. Immune effectors required for hepatitis B virus clearance. Proc. Natl Acad. Sci. USA 107, 798\u2013802 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3277_CR131","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","volume":"32","author":"GJ Webster","year":"2000","unstructured":"Webster, G. J. et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32, 1117\u20131124 (2000).","journal-title":"Hepatology"},{"key":"BFnri3277_CR132","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1084\/jem.20072076","volume":"205","author":"A Das","year":"2008","unstructured":"Das, A. et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205, 2111\u20132124 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnri3277_CR133","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI33402","volume":"118","author":"AR Lopes","year":"2008","unstructured":"Lopes, A. R. et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J. Clin. Invest. 118, 1835\u20131845 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnri3277_CR134","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.24249","volume":"53","author":"A Schurich","year":"2011","unstructured":"Schurich, A. et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 53, 1494\u20131503 (2011).","journal-title":"Hepatology"},{"key":"BFnri3277_CR135","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1182\/blood-2011-05-353789","volume":"119","author":"LJ Walker","year":"2012","unstructured":"Walker, L. J. et al. Human MAIT and CD8\u03b1\u03b1 cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 119, 422\u2013433 (2012).","journal-title":"Blood"},{"key":"BFnri3277_CR136","first-page":"S3","volume":"121","author":"EJ Heathcote","year":"2008","unstructured":"Heathcote, E. J. Demography and presentation of chronic hepatitis B virus infection. Am. J. Med. 121, S3\u2013S11 (2008).","journal-title":"Am. J. Med."},{"key":"BFnri3277_CR137","first-page":"1387","volume":"22","author":"MH Chang","year":"1995","unstructured":"Chang, M. H. et al. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 22, 1387\u20131392 (1995).","journal-title":"Hepatology"},{"key":"BFnri3277_CR138","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00239-007-0054-1","volume":"65","author":"Y Zhou","year":"2007","unstructured":"Zhou, Y. & Holmes, E. C. Bayesian estimates of the evolutionary rate and age of hepatitis B virus. J. Mol. Evol. 65, 197\u2013205 (2007).","journal-title":"J. Mol. Evol."},{"key":"BFnri3277_CR139","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","volume":"137","author":"C Dunn","year":"2009","unstructured":"Dunn, C. et al. Temporal analysis of early immune responses in patients with acute hepatitis B infection. Gastroenterology 137, 1289\u20131300 (2009).","journal-title":"Gastroenterology"},{"key":"BFnri3277_CR140","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1073\/pnas.0401771101","volume":"101","author":"S Wieland","year":"2004","unstructured":"Wieland, S., Thimme, R., Purcell, R. H. & Chisari, F. V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl Acad. Sci. USA 101, 6669\u20136674 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3277_CR141","doi-asserted-by":"publisher","first-page":"e26315","DOI":"10.1371\/journal.pone.0026315","volume":"6","author":"IE Vincent","year":"2011","unstructured":"Vincent, I. E. et al. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS ONE 6, e26315 (2011).","journal-title":"PLoS ONE"},{"key":"BFnri3277_CR142","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1172\/JCI44198","volume":"121","author":"J Publicover","year":"2011","unstructured":"Publicover, J. et al. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J. Clin. Invest. 121, 1154\u20131162 (2011). This study provides mechanistic evidence for the role of IL-21 in determining long-term outcome after HBV infection.","journal-title":"J. Clin. Invest."},{"key":"BFnri3277_CR143","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(82)90977-1","volume":"1","author":"F Barin","year":"1982","unstructured":"Barin, F. et al. Immune response in neonates to hepatitis B vaccine. Lancet 1, 251\u2013253 (1982).","journal-title":"Lancet"},{"key":"BFnri3277_CR144","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/infdis\/jir852","volume":"205","author":"WJ Su","year":"2012","unstructured":"Su, W. J. et al. Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan. J. Infect. Dis. 205, 757\u2013762 (2012).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR145","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(84)92388-2","volume":"1","author":"VC Wong","year":"1984","unstructured":"Wong, V. C. et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet 1, 921\u2013926 (1984).","journal-title":"Lancet"},{"key":"BFnri3277_CR146","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.vaccine.2011.01.025","volume":"29","author":"Q Wu","year":"2011","unstructured":"Wu, Q. et al. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine 29, 2302\u20132307 (2011).","journal-title":"Vaccine"},{"key":"BFnri3277_CR147","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/cmi.2010.34","volume":"7","author":"L Koumbi","year":"2010","unstructured":"Koumbi, L. et al. Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+\/HBeAg\u2212 mothers. Cell. Mol. Immunol. 7, 454\u2013458 (2010).","journal-title":"Cell. Mol. Immunol."},{"key":"BFnri3277_CR148","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2334-10-103","volume":"10","author":"H Komatsu","year":"2010","unstructured":"Komatsu, H. et al. Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus. BMC Infect. Dis. 10, 103 (2010).","journal-title":"BMC Infect. Dis."},{"key":"BFnri3277_CR149","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.1185350","volume":"328","author":"SG Hansen","year":"2010","unstructured":"Hansen, S. G. et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 328, 102\u2013106 (2010).","journal-title":"Science"},{"key":"BFnri3277_CR150","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.188.6.1047","volume":"188","author":"B Polic","year":"1998","unstructured":"Polic, B. et al. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188, 1047\u20131054 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnri3277_CR151","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1084\/jem.20050882","volume":"202","author":"AW Sylwester","year":"2005","unstructured":"Sylwester, A. W. et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202, 673\u2013685 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnri3277_CR152","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-4933-3-11","volume":"3","author":"H Komatsu","year":"2006","unstructured":"Komatsu, H. et al. Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses. Immun. Ageing 3, 11 (2006).","journal-title":"Immun. Ageing"},{"key":"BFnri3277_CR153","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nm0402-379","volume":"8","author":"V Appay","year":"2002","unstructured":"Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nature Med. 8, 379\u2013385 (2002).","journal-title":"Nature Med."},{"key":"BFnri3277_CR154","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1440-1711.2005.01321.x","volume":"83","author":"J Northfield","year":"2005","unstructured":"Northfield, J., Lucas, M., Jones, H., Young, N. T. & Klenerman, P. Does memory improve with age? CD85j (ILT-2\/LIR-1) expression on CD8 T cells correlates with 'memory inflation' in human cytomegalovirus infection. Immunol. Cell Biol. 83, 182\u2013188 (2005).","journal-title":"Immunol. Cell Biol."},{"key":"BFnri3277_CR155","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-4933-8-10","volume":"8","author":"M Wills","year":"2011","unstructured":"Wills, M. et al. Report from the second cytomegalovirus and immunosenescence workshop. Immun. Ageing 8, 10 (2011).","journal-title":"Immun. Ageing"},{"key":"BFnri3277_CR156","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.4049\/jimmunol.170.4.2022","volume":"170","author":"U Karrer","year":"2003","unstructured":"Karrer, U. et al. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J. Immunol. 170, 2022\u20132029 (2003).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR157","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.it.2011.11.005","volume":"33","author":"GA O'Hara","year":"2012","unstructured":"O'Hara, G. A., Welten, S. P., Klenerman, P. & Arens, R. Memory T cell inflation: understanding cause and effect. Trends Immunol. 33, 84\u201390 (2012).","journal-title":"Trends Immunol."},{"key":"BFnri3277_CR158","doi-asserted-by":"publisher","first-page":"e1002313","DOI":"10.1371\/journal.ppat.1002313","volume":"7","author":"N Torti","year":"2011","unstructured":"Torti, N., Walton, S. M., Brocker, T., Rulicke, T. & Oxenius, A. Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog. 7, e1002313 (2011). This study provides a demonstration of the anatomical and cellular requirements for memory inflation in CMV infection.","journal-title":"PLoS Pathog."},{"key":"BFnri3277_CR159","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1093\/infdis\/jir632","volume":"204","author":"EP Ehlinger","year":"2011","unstructured":"Ehlinger, E. P. et al. Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants. J. Infect. Dis. 204, 1672\u20131682 (2011).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR160","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/rmv.695","volume":"21","author":"MJ Cannon","year":"2011","unstructured":"Cannon, M. J., Hyde, T. B. & Schmid, D. S. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev. Med. Virol. 21, 240\u2013255 (2011).","journal-title":"Rev. Med. Virol."},{"key":"BFnri3277_CR161","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1128\/JVI.00052-07","volume":"81","author":"DJ Miles","year":"2007","unstructured":"Miles, D. J. et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J. Virol. 81, 5766\u20135776 (2007).","journal-title":"J. Virol."},{"key":"BFnri3277_CR162","doi-asserted-by":"publisher","first-page":"e2905","DOI":"10.1371\/journal.pone.0002905","volume":"3","author":"DJ Miles","year":"2008","unstructured":"Miles, D. J. et al. Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS ONE 3, e2905 (2008).","journal-title":"PLoS ONE"},{"key":"BFnri3277_CR163","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1203\/01.PDR.0000104150.85437.FE","volume":"55","author":"MA Elbou Ould","year":"2004","unstructured":"Elbou Ould, M. A. et al. Cellular immune response of fetuses to cytomegalovirus. Pediatr. Res. 55, 280\u2013286 (2004).","journal-title":"Pediatr. Res."},{"key":"BFnri3277_CR164","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1172\/JCI200317470","volume":"111","author":"A Marchant","year":"2003","unstructured":"Marchant, A. et al. Mature CD8+ T lymphocyte response to viral infection during fetal life. J. Clin. Invest. 111, 1747\u20131755 (2003). This study provides the first demonstration of effector CD8+ T cell responses specific for CMV generated during prenatal life.","journal-title":"J. Clin. Invest."},{"key":"BFnri3277_CR165","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1086\/521196","volume":"196","author":"B Pedron","year":"2007","unstructured":"Pedron, B. et al. Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J. Infect. Dis. 196, 1033\u20131043 (2007).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR166","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1084\/jem.20090348","volume":"207","author":"D Vermijlen","year":"2010","unstructured":"Vermijlen, D. et al. Human cytomegalovirus elicits fetal \u03b3\u03b4 T cell responses in utero. J. Exp. Med. 207, 807\u2013821 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnri3277_CR167","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.4049\/jimmunol.172.5.3260","volume":"172","author":"W Tu","year":"2004","unstructured":"Tu, W. et al. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J. Immunol. 172, 3260\u20133267 (2004).","journal-title":"J. Immunol."},{"key":"BFnri3277_CR168","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature05762","volume":"447","author":"ES Barton","year":"2007","unstructured":"Barton, E. S. et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326\u2013329 (2007).","journal-title":"Nature"},{"key":"BFnri3277_CR169","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/vim.2008.0086","volume":"22","author":"EJ Yager","year":"2009","unstructured":"Yager, E. J. et al. \u03b3-Herpesvirus-induced protection against bacterial infection is transient. Viral Immunol. 22, 67\u201372 (2009).","journal-title":"Viral Immunol."},{"key":"BFnri3277_CR170","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","volume":"344","author":"SB Boppana","year":"2001","unstructured":"Boppana, S. B., Rivera, L. B., Fowler, K. B., Mach, M. & Britt, W. J. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344, 1366\u20131371 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnri3277_CR171","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","volume":"360","author":"RF Pass","year":"2009","unstructured":"Pass, R. F. et al. Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 360, 1191\u20131199 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnri3277_CR172","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","volume":"12","author":"MA Kharfan-Dabaja","year":"2012","unstructured":"Kharfan-Dabaja, M. A. et al. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect. Dis. 12, 290\u2013299 (2012).","journal-title":"Lancet Infect. Dis."},{"key":"BFnri3277_CR173","unstructured":"UNAIDS. Countdown to zero: Global plan towards elimination of new HIV infections among children by 2015 and keeping their mothers alive (UNAIDS, 2011)."},{"key":"BFnri3277_CR174","doi-asserted-by":"publisher","first-page":"90ps27","DOI":"10.1126\/scitranslmed.3001880","volume":"3","author":"G Sanchez-Schmitz","year":"2011","unstructured":"Sanchez-Schmitz, G. & Levy, O. Development of newborn and infant vaccines. Sci. Transl. Med. 3, 90ps27 (2011).","journal-title":"Sci. Transl. Med."},{"key":"BFnri3277_CR175","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","volume":"143","author":"DW Kimberlin","year":"2003","unstructured":"Kimberlin, D. W. et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr. 143, 16\u201325 (2003).","journal-title":"J. Pediatr."},{"issue":"Suppl. 4","key":"BFnri3277_CR176","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.jcv.2009.08.012","volume":"46","author":"S Oliver","year":"2009","unstructured":"Oliver, S. et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J. Clin. Virol. 46 (Suppl. 4), S22\u2013S26 (2009).","journal-title":"J. Clin. Virol."},{"key":"BFnri3277_CR177","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199907083410203","volume":"341","author":"A Kovacs","year":"1999","unstructured":"Kovacs, A. et al. Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N. Engl. J. Med. 341, 77\u201384 (1999). This study demonstrates the importance of viral co-infections in early life: infants infected with both HIV and CMV had higher rates of disease progression by 18 months of age than infants infected only with HIV.","journal-title":"N. Engl. J. Med."},{"key":"BFnri3277_CR178","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/infdis\/jir060","volume":"203","author":"PW Hunt","year":"2011","unstructured":"Hunt, P. W. et al. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J. Infect. Dis. 203, 1474\u20131483 (2011).","journal-title":"J. Infect. Dis."},{"key":"BFnri3277_CR179","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.clim.2009.05.020","volume":"133","author":"R van Gent","year":"2009","unstructured":"van Gent, R. et al. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin. Immunol. 133, 95\u2013107 (2009).","journal-title":"Clin. Immunol."},{"key":"BFnri3277_CR180","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1086\/521165","volume":"45","author":"J Warszawski","year":"2007","unstructured":"Warszawski, J. et al. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French pediatric cohort. Clin. Infect. Dis. 45, 785\u2013794 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"BFnri3277_CR181","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2007.08.010","volume":"27","author":"SG Deeks","year":"2007","unstructured":"Deeks, S. G. & Walker, B. D. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27, 406\u2013416 (2007).","journal-title":"Immunity"},{"key":"BFnri3277_CR182","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/0016-5085(92)91188-A","volume":"103","author":"FE De Jongh","year":"1992","unstructured":"De Jongh, F. E. et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 103, 1630\u20131635 (1992).","journal-title":"Gastroenterology"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nri3277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri3277","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri3277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:42:31Z","timestamp":1744288951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nri3277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,24]]},"references-count":182,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["BFnri3277"],"URL":"https:\/\/doi.org\/10.1038\/nri3277","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,24]]},"assertion":[{"value":"24 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}